BUZZ-Bain Capital-backed Heartflow set for Nasdaq debut after upsized $317 million IPO

Reuters

Aug 08

** Bain Capital-backed medical technology firm Heartflow HTFL.O set to begin trading on the Nasdaq under ticker symbol "HTFL" on Friday

** HTFL late Thursday sold 16.7 million shares at $19 apiece for gross proceeds of $316.7 million in an upsized IPO

** Mountain View, California-based HTFL upsized its offering and raised the proposed range earlier this week reflecting strong demand

** HTFL marks the third sizable medtech listing in New York in less than a month

** Founded in 2007 as Cardiovascular Simulation, Heartflow's AI-enabled products help physicians to diagnose and treat heart disease

** J.P. Morgan, Morgan Stanley and Piper Sandler were the lead underwriters for the offering

(Reporting by Arasu Kannagi Basil in Bengaluru)

((ArasuKannagi.Basil@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2557578996"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2557578996\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2557578996?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-08 22:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2557578996","market":"nz","top_or_hot":-1,"title":"BUZZ-Bain Capital-backed Heartflow set for Nasdaq debut after upsized $317 million IPO","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Bain Capital-backed Heartflow set for Nasdaq debut after upsized $317 million IPO</title></head><body><p>** Bain Capital-backed medical technology firm Heartflow <span>HTFL.O</span> set to begin trading on the Nasdaq under ticker symbol \"HTFL\" on Friday</p><p>** HTFL late Thursday sold 16.7 million shares at $19 apiece for gross proceeds of $316.7 million in an upsized IPO </p><p>** Mountain View, California-based HTFL upsized its offering and raised the proposed range <span>earlier</span> this week reflecting strong demand</p><p>** HTFL marks the third sizable medtech listing in New York in less than a month </p><p>** Founded in 2007 as Cardiovascular Simulation, Heartflow's AI-enabled products help physicians to diagnose and treat heart disease</p><p>** J.P. Morgan, <a href=\"https://laohu8.com/S/MTK\">Morgan Stanley</a> and Piper Sandler were the lead underwriters for the offering</p><p> (Reporting by Arasu Kannagi Basil in Bengaluru)</p><p> ((ArasuKannagi.Basil@thomsonreuters.com))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-Bain Capital-backed Heartflow set for Nasdaq debut after upsized $317 million IPO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-Bain Capital-backed Heartflow set for Nasdaq debut after upsized $317 million IPO\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-08-08 22:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Bain Capital-backed Heartflow set for Nasdaq debut after upsized $317 million IPO</title></head><body><p>** Bain Capital-backed medical technology firm Heartflow <span>HTFL.O</span> set to begin trading on the Nasdaq under ticker symbol \"HTFL\" on Friday</p><p>** HTFL late Thursday sold 16.7 million shares at $19 apiece for gross proceeds of $316.7 million in an upsized IPO </p><p>** Mountain View, California-based HTFL upsized its offering and raised the proposed range <span>earlier</span> this week reflecting strong demand</p><p>** HTFL marks the third sizable medtech listing in New York in less than a month </p><p>** Founded in 2007 as Cardiovascular Simulation, Heartflow's AI-enabled products help physicians to diagnose and treat heart disease</p><p>** J.P. Morgan, <a href=\"https://laohu8.com/S/MTK\">Morgan Stanley</a> and Piper Sandler were the lead underwriters for the offering</p><p> (Reporting by Arasu Kannagi Basil in Bengaluru)</p><p> ((ArasuKannagi.Basil@thomsonreuters.com))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PIPR","symbol_name":"派杰投资","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250808:nL6N3U00GU:1","article_id":"2557578996","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2557578996","pubTimestamp":1754663214,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-Bain Capital-backed Heartflow set for Nasdaq debut after upsized $317 million IPO** Bain Capital-backed medical technology firm Heartflow HTFL.O set to begin trading on the Nasdaq under ticker symbol \"HTFL\" on Friday** HTFL late Thursday sold 16.7 million shares at $19 apiece for gross proceeds of $316.7 million in an upsized IPO ** Mountain View, California-based HTFL upsized its offering and raised the proposed range earlier this week reflecting strong demand** HTFL marks the third sizable medtech listing in New York in less than a month ** Founded in 2007 as Cardiovascular Simulation, Heartflow's AI-enabled products help physicians to diagnose and treat heart disease** J.P. Morgan, Morgan Stanley and Piper Sandler were the lead underwriters for the offering  ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"PIPR":"派杰投资","BK4127":"投资银行业与经纪业","HTFL":"HeartFlow Inc"},"translate_title":"巴兹-贝恩资本支持的Heartflow在IPO规模扩大3.17亿美元后将在纳斯达克首次亮相","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HTFL":0.9,"PIPR":0.9},"content_text":"BUZZ-Bain Capital-backed Heartflow set for Nasdaq debut after upsized $317 million IPO** Bain Capital-backed medical technology firm Heartflow HTFL.O set to begin trading on the Nasdaq under ticker symbol \"HTFL\" on Friday** HTFL late Thursday sold 16.7 million shares at $19 apiece for gross proceeds of $316.7 million in an upsized IPO ** Mountain View, California-based HTFL upsized its offering and raised the proposed range earlier this week reflecting strong demand** HTFL marks the third sizable medtech listing in New York in less than a month ** Founded in 2007 as Cardiovascular Simulation, Heartflow's AI-enabled products help physicians to diagnose and treat heart disease** J.P. Morgan, Morgan Stanley and Piper Sandler were the lead underwriters for the offering (Reporting by Arasu Kannagi Basil in Bengaluru) ((ArasuKannagi.Basil@thomsonreuters.com))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"shareholding,corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}